PAK4 normally stabilizes β-catenin to suppress T-cell infiltration; thus, selectively inhibiting PAK4 normalizes the tumor vascular network and facilitates the influx of CD8+ T cells, sensitizing resistant TNBC tumors to PD-1 blockade [108]. The gene discussed is PAK4; the disease is neoplasm.